# Protective Effect of Ulinastatin Against Negative Inflammatory Response and Organ Dysfunction After Acute Type a Aortic Dissection Surgery (PANDA I)

> **NCT04711889** · NA · COMPLETED · sponsor: **Nanjing Medical University** · enrollment: 203 (actual)

## Conditions studied

- Acute Aortic Syndrome
- Type a Aortic Dissection

## Interventions

- **DRUG:** Ulinastatin
- **DRUG:** Blank control

## Key facts

- **NCT ID:** NCT04711889
- **Lead sponsor:** Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-01
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-06-30
- **Target enrollment:** 203 (ACTUAL)
- **Last updated:** 2024-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04711889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04711889, "Protective Effect of Ulinastatin Against Negative Inflammatory Response and Organ Dysfunction After Acute Type a Aortic Dissection Surgery (PANDA I)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04711889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*